Poulomee Bose
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Glucosamine amends CNS pathology in mucopolysaccharidosis IIIC mouse expressing misfolded HGSNAT.
Journal: The Journal of experimental medicine
Published: September 08, 2021
Correction to: The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: June 08, 2021
Early defects in mucopolysaccharidosis type IIIC disrupt excitatory synaptic transmission.
Journal: JCI insight
Published: July 07, 2020
Neuropathophysiology of Lysosomal Storage Diseases: Synaptic Dysfunction as a Starting Point for Disease Progression.
Journal: Journal of clinical medicine
Published: January 31, 2020
Novel small molecule TRVA242 targets neuromuscular junction in amyotrophic lateral sclerosis.
Journal: Neural regeneration research
Published: December 12, 2019
The Novel Small Molecule TRVA242 Stabilizes Neuromuscular Junction Defects in Multiple Animal Models of Amyotrophic Lateral Sclerosis.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: July 26, 2019
Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43.
Journal: Journal of neurophysiology
Published: November 22, 2018
Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin.
Journal: Frontiers in neuroscience
Published: September 13, 2015
Dopamine preferentially inhibits NMDA receptor-mediated EPSCs by acting on presynaptic D1 receptors in nucleus accumbens during postnatal development.
Journal: PloS one
Published: September 19, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026